Harbour Investments »

Cyclacel Pharmaceuticals shares owned by Harbour Investments

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (CYCC) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Harbour Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $34 13 2.69

More positions owned by Harbour Investments

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pacer Fds Tr Pacer Us Small (CALF)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Apple (AAPL)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Value Line Divid In SHS (FVD)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Fidelity Covington Trust Msci Hlth Care I (FHLC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Procter & Gamble Company (PG)

View all positions for Harbour Investments

Top funds holding Cyclacel Pharmaceuticals

Point72 Asset Management
McIlrath & Eck
Advisor Group Holdings
Wells Fargo & Company
Signature
Harbour Investments

View all funds holding Cyclacel Pharmaceuticals